| scholarly article | Q13442814 |
| P50 | author | Adam C Straub | Q62514795 |
| P2093 | author name string | Jeffrey S Isenberg | |
| Helene M Altmann | |||
| Kedar Ghimire | |||
| P2860 | cites work | Stimulatory effect of IGF-I and VEGF on eNOS message, protein expression, eNOS phosphorylation and nitric oxide production in rat glomeruli, and the involvement of PI3-K signaling pathway | Q47861985 |
| Nitric oxide regulation of myocardial contractility and calcium cycling: independent impact of neuronal and endothelial nitric oxide synthases | Q47891975 | ||
| Combination of angiotensin II and l-NG-nitroarginine methyl ester exacerbates mitochondrial dysfunction and oxidative stress to cause heart failure. | Q49022015 | ||
| Absence of an effect of high nitrate intake from beetroot juice on blood pressure in treated hypertensive individuals: a randomized controlled trial. | Q50262754 | ||
| Reconstitution of an endothelial nitric-oxide synthase (eNOS), hsp90, and caveolin-1 complex in vitro. Evidence that hsp90 facilitates calmodulin stimulated displacement of eNOS from caveolin-1. | Q50336016 | ||
| Physiological levels of thrombospondin-1 decrease NO-dependent vasodilation in coronary microvessels from aged rats. | Q50896297 | ||
| Nitric oxide synthase inhibition abolishes exercise-mediated protection against isoproterenol-induced cardiac hypertrophy in female mice. | Q51051226 | ||
| TSP1-CD47 signaling is upregulated in clinical pulmonary hypertension and contributes to pulmonary arterial vasculopathy and dysfunction. | Q51392738 | ||
| ET-1 Stimulates Superoxide Production by eNOS Following Exposure of Vascular Endothelial Cells to Endotoxin. | Q51535768 | ||
| Modeling the influence of superoxide dismutase on superoxide and nitric oxide interactions, including reversible inhibition of oxygen consumption. | Q52016494 | ||
| A tutorial on the diffusibility and reactivity of free nitric oxide. | Q52275127 | ||
| Exercise does not activate the β3 adrenergic receptor-eNOS pathway, but reduces inducible NOS expression to protect the heart of obese diabetic mice. | Q53786654 | ||
| Blocking Thrombospondin-1/CD47 Signaling Alleviates Deleterious Effects of Aging on Tissue Responses to Ischemia | Q58315878 | ||
| Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms | Q59091659 | ||
| Neuronal nitric oxide synthase is up-regulated by angiotensin II and attenuates NADPH oxidase activity and facilitates relaxation in murine left ventricular myocytes | Q59114615 | ||
| The ultrastructure of mammalian arterioles and precapillary sphincters | Q71206374 | ||
| Peroxynitrite irreversibly decreases diastolic and systolic function in cardiac muscle | Q73370544 | ||
| Soluble nitric oxide donor and surfactant improve oxygenation and pulmonary hypertension in porcine lung injury | Q74177509 | ||
| Endogenous endothelial nitric oxide synthase-derived nitric oxide is a physiological regulator of myocardial oxygen consumption | Q77330510 | ||
| Endoglin increases eNOS expression by modulating Smad2 protein levels and Smad2-dependent TGF-beta signaling | Q79291122 | ||
| Cardiomyocyte-restricted restoration of nitric oxide synthase 3 attenuates left ventricular remodeling after chronic pressure overload | Q80117014 | ||
| Successful perioperative utilisation of inhaled nitric oxide in mitral valve surgery | Q83006656 | ||
| NO-NSAIDs. Part 3: nitric oxide-releasing prodrugs of non-steroidal anti-inflammatory drugs | Q83785597 | ||
| A new approach to antiglaucoma drugs: carbonic anhydrase inhibitors with or without NO donating moieties. Mechanism of action and preliminary pharmacology | Q84679919 | ||
| Inhaled nitric oxide versus sodium nitroprusside for preoperative evaluation of pulmonary hypertension in heart transplant candidates | Q85764678 | ||
| Heart Disease and Stroke Statistics--2015 Update: A Report From the American Heart Association | Q22241921 | ||
| NOSIP, a novel modulator of endothelial nitric oxide synthase activity | Q24290718 | ||
| NOSTRIN: a protein modulating nitric oxide release and subcellular distribution of endothelial nitric oxide synthase | Q24321312 | ||
| Pin1 prolyl isomerase regulates endothelial nitric oxide synthase | Q24617827 | ||
| Uncoupled cardiac nitric oxide synthase mediates diastolic dysfunction | Q24650649 | ||
| Cytoglobin is expressed in the vasculature and regulates cell respiration and proliferation via nitric oxide dioxygenation | Q24654466 | ||
| Obligatory role of neuronal nitric oxide synthase in the heart's antioxidant adaptation with exercise | Q27302343 | ||
| Structure of cinaciguat (BAY 58-2667) bound to Nostoc H-NOX domain reveals insights into heme-mimetic activation of the soluble guanylyl cyclase | Q27661554 | ||
| CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1 | Q28251463 | ||
| Beta-actin association with endothelial nitric-oxide synthase modulates nitric oxide and superoxide generation from the enzyme | Q28266096 | ||
| NO dioxygenase activity in hemoglobins is ubiquitous in vitro, but limited by reduction in vivo | Q28472607 | ||
| Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice | Q28508575 | ||
| Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling | Q28609890 | ||
| Two functionally distinct pools of eNOS in endothelium are facilitated by myoendothelial junction lipid composition | Q30276930 | ||
| Hemoglobin α/eNOS coupling at myoendothelial junctions is required for nitric oxide scavenging during vasoconstriction | Q30303168 | ||
| The myoendothelial junction: connections that deliver the message. | Q30384545 | ||
| Endothelial cell expression of haemoglobin α regulates nitric oxide signalling | Q30419307 | ||
| Compartmentalized connexin 43 s-nitrosylation/denitrosylation regulates heterocellular communication in the vessel wall | Q30432944 | ||
| Thrombospondin-1 and angiotensin II inhibit soluble guanylyl cyclase through an increase in intracellular calcium concentration | Q30503997 | ||
| Cardiac CD47 drives left ventricular heart failure through Ca2+-CaMKII-regulated induction of HDAC3. | Q30618651 | ||
| Riociguat for the treatment of pulmonary arterial hypertension | Q33163083 | ||
| Thrombospondin-1 activation of signal-regulatory protein-α stimulates reactive oxygen species production and promotes renal ischemia reperfusion injury | Q33660552 | ||
| Tumor microenvironment-based feed-forward regulation of NOS2 in breast cancer progression | Q33674627 | ||
| Differential regulation of inducible and endothelial nitric oxide synthase by kinin B1 and B2 receptors | Q33695494 | ||
| Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer. | Q33739233 | ||
| Thrombospondin-1 is an inhibitor of pharmacological activation of soluble guanylate cyclase | Q33772904 | ||
| Dose dependent effects of reactive oxygen and nitrogen species on the function of neuronal nitric oxide synthase | Q33815495 | ||
| Nitroxyl anion exerts redox-sensitive positive cardiac inotropy in vivo by calcitonin gene-related peptide signaling. | Q33943302 | ||
| Identification of a neuronal nitric oxide synthase in isolated cardiac mitochondria using electrochemical detection | Q33950422 | ||
| The N-terminal portion of autoinhibitory element modulates human endothelial nitric-oxide synthase activity through coordinated controls of phosphorylation at Thr495 and Ser1177. | Q34007426 | ||
| Endothelial nitric-oxide synthase (eNOS) is activated through G-protein-coupled receptor kinase-interacting protein 1 (GIT1) tyrosine phosphorylation and Src protein | Q34073943 | ||
| Matricellular proteins: extracellular modulators of cell function | Q34149511 | ||
| Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxation | Q34275612 | ||
| Voltage-dependent anion channel-2 interaction with nitric oxide synthase enhances pulmonary artery endothelial cell nitric oxide production | Q34290941 | ||
| Age-associated induction of cell membrane CD47 limits basal and temperature-induced changes in cutaneous blood flow | Q34527600 | ||
| The biological lifetime of nitric oxide: implications for the perivascular dynamics of NO and O2. | Q34600440 | ||
| Effects of nitric oxide donors on cardiac contractility in wild-type and myoglobin-deficient mice | Q35044405 | ||
| Nitric oxide-dependent activation of CaMKII increases diastolic sarcoplasmic reticulum calcium release in cardiac myocytes in response to adrenergic stimulation | Q35086912 | ||
| Exercise protects against myocardial ischemia-reperfusion injury via stimulation of β(3)-adrenergic receptors and increased nitric oxide signaling: role of nitrite and nitrosothiols | Q35119810 | ||
| PKC-dependent phosphorylation of eNOS at T495 regulates eNOS coupling and endothelial barrier function in response to G+ -toxins | Q35206447 | ||
| Endothelial nitric oxide synthase dimerization is regulated by heat shock protein 90 rather than by phosphorylation | Q35230816 | ||
| Thrombospondin-1 regulates blood flow via CD47 receptor-mediated activation of NADPH oxidase 1. | Q35379312 | ||
| Nitric oxide synthase generates nitric oxide locally to regulate compartmentalized protein S-nitrosylation and protein trafficking | Q35544395 | ||
| Simulation of the diffusion and reaction of endogenously produced nitric oxide | Q35684444 | ||
| Update on mechanism and catalytic regulation in the NO synthases. | Q35767355 | ||
| Pre-Clinical Development of a Humanized Anti-CD47 Antibody with Anti-Cancer Therapeutic Potential | Q35781873 | ||
| eNOS at a glance | Q35782010 | ||
| Activated CD47 promotes pulmonary arterial hypertension through targeting caveolin-1. | Q35792731 | ||
| Mechanisms of action of PDE5 inhibition in erectile dysfunction | Q35821251 | ||
| Structure Guided Chemical Modifications of Propylthiouracil Reveal Novel Small Molecule Inhibitors of Cytochrome b5 Reductase 3 That Increase Nitric Oxide Bioavailability | Q35860552 | ||
| eNOS activation and NO function: structural motifs responsible for the posttranslational control of endothelial nitric oxide synthase activity | Q35889758 | ||
| Requirement of argininosuccinate lyase for systemic nitric oxide production. | Q35948795 | ||
| Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloid-derived suppressor cells through modulation of vascular endothelial growth factor release | Q35981563 | ||
| SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase | Q35990346 | ||
| Identification of Golgi-localized acyl transferases that palmitoylate and regulate endothelial nitric oxide synthase | Q36118353 | ||
| Reexpression of caveolin-1 in endothelium rescues the vascular, cardiac, and pulmonary defects in global caveolin-1 knockout mice | Q36228990 | ||
| Deficient ryanodine receptor S-nitrosylation increases sarcoplasmic reticulum calcium leak and arrhythmogenesis in cardiomyocytes | Q36300139 | ||
| Cardiac capsaicin-sensitive sensory nerves regulate myocardial relaxation via S-nitrosylation of SERCA: role of peroxynitrite | Q36456854 | ||
| Beta3-adrenoreceptor stimulation ameliorates myocardial ischemia-reperfusion injury via endothelial nitric oxide synthase and neuronal nitric oxide synthase activation | Q36652837 | ||
| Inducible nitric oxide synthase deficiency protects the heart from systolic overload-induced ventricular hypertrophy and congestive heart failure. | Q36662476 | ||
| Clinical indication for use and outcomes after inhaled nitric oxide therapy | Q36663234 | ||
| Gene silencing of CD47 and antibody ligation of thrombospondin-1 enhance ischemic tissue survival in a porcine model: implications for human disease | Q36725128 | ||
| S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds | Q36780079 | ||
| Differential effects of the peroxynitrite donor, SIN-1, on atrial and ventricular myocyte electrophysiology | Q36828341 | ||
| Protocol: does sodium nitrite administration reduce ischaemia-reperfusion injury in patients presenting with acute ST segment elevation myocardial infarction? Nitrites in acute myocardial infarction (NIAMI). | Q36859185 | ||
| Targeting nitric oxide signaling with nNOS inhibitors as a novel strategy for the therapy and prevention of human melanoma. | Q36991145 | ||
| Ischemic postconditioning protects the heart against ischemia-reperfusion injury via neuronal nitric oxide synthase in the sarcoplasmic reticulum and mitochondria | Q37030270 | ||
| Thrombospondin-1 and CD47 regulate blood pressure and cardiac responses to vasoactive stress | Q37144638 | ||
| Targeting of phospholamban by peroxynitrite decreases beta-adrenergic stimulation in cardiomyocytes | Q37221679 | ||
| Redox modulation of endothelial nitric oxide synthase by glutaredoxin-1 through reversible oxidative post-translational modification | Q37270079 | ||
| Calcium/calmodulin-dependent kinase II and nitric oxide synthase 1-dependent modulation of ryanodine receptors during β-adrenergic stimulation is restricted to the dyadic cleft | Q37338829 | ||
| Endothelial nitric oxide synthase decreases beta-adrenergic responsiveness via inhibition of the L-type Ca2+ current | Q37347977 | ||
| Thrombospondin-1-CD47 blockade and exogenous nitrite enhance ischemic tissue survival, blood flow and angiogenesis via coupled NO-cGMP pathway activation | Q37400455 | ||
| Antiplatelet effects of dietary nitrate in healthy volunteers: involvement of cGMP and influence of sex. | Q37426198 | ||
| Inhaled nitric oxide for the treatment of pulmonary arterial hypertension | Q38149031 | ||
| Strategies to increase nitric oxide signalling in cardiovascular disease | Q38565004 | ||
| Targeting NO/cGMP Signaling in the CNS for Neurodegeneration and Alzheimer's Disease | Q38989533 | ||
| A novel liposomal nanomedicine for nitric oxide delivery and breast cancer treatment | Q39065038 | ||
| HDAC3 is crucial in shear- and VEGF-induced stem cell differentiation toward endothelial cells | Q39742798 | ||
| Site-specific dephosphorylation of endothelial nitric oxide synthase by protein phosphatase 2A: evidence for crosstalk between phosphorylation sites | Q40681189 | ||
| Phosphoinositide 3-kinase gamma controls inflammation-induced myocardial depression via sequential cAMP and iNOS signalling | Q41019127 | ||
| Polymeric-based perivascular delivery of a nitric oxide donor inhibits intimal thickening after balloon denudation arterial injury: role of nuclear factor-kappaB. | Q41719642 | ||
| Chk1 and Hsp90 cooperatively regulate phosphorylation of endothelial nitric oxide synthase at serine 1179. | Q42496042 | ||
| Interaction of the endothelial nitric oxide synthase with the CAT-1 arginine transporter enhances NO release by a mechanism not involving arginine transport | Q42815226 | ||
| Where is endothelial nitric oxide synthase more critical: plasma membrane or Golgi? | Q43002344 | ||
| Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms | Q43926534 | ||
| Chaperone-dependent regulation of endothelial nitric-oxide synthase intracellular trafficking by the co-chaperone/ubiquitin ligase CHIP. | Q44595338 | ||
| Structural Elements Contribute to the Calcium/Calmodulin Dependence on Enzyme Activation in Human Endothelial Nitric-oxide Synthase | Q44619462 | ||
| A defect of neuronal nitric oxide synthase increases xanthine oxidase-derived superoxide anion and attenuates the control of myocardial oxygen consumption by nitric oxide derived from endothelial nitric oxide synthase | Q45214919 | ||
| Exercise-induced cardioprotection: a role for eNOS uncoupling and NO metabolites. | Q45941940 | ||
| The nitric oxide-cGMP signaling pathway differentially regulates presynaptic structural plasticity in cone and rod cells. | Q46367970 | ||
| NO-dependent CaMKII activation during β-adrenergic stimulation of cardiac muscle. | Q46425198 | ||
| Comparison of the effects of tert-butyl hydroperoxide and peroxynitrite on the oxidative damage to isolated beef heart mitochondria | Q46578144 | ||
| Inhibition of endothelial nitric oxide synthase activity by proline-rich tyrosine kinase 2 in response to fluid shear stress and insulin | Q46593138 | ||
| Agonist-stimulated endothelial nitric oxide synthase activation and vascular relaxation. Role of eNOS phosphorylation at Tyr83. | Q46838387 | ||
| The role of eNOS phosphorylation in causing drug-induced vascular injury. | Q46909228 | ||
| Functional relevance of Golgi- and plasma membrane-localized endothelial NO synthase in reconstituted endothelial cells | Q46973331 | ||
| Nitrite infusion in humans and nonhuman primates: endocrine effects, pharmacokinetics, and tolerance formation | Q46983570 | ||
| P433 | issue | 3 | |
| P304 | page(s) | C254-C262 | |
| P577 | publication date | 2016-12-14 | |
| P1433 | published in | American Journal of Physiology - Cell Physiology | Q2227080 |
| P1476 | title | Nitric oxide: what's new to NO? | |
| P478 | volume | 312 |
| Q47147427 | Acute Effects of Nitrate-Rich Beetroot Juice on Blood Pressure, Hemostasis and Vascular Inflammation Markers in Healthy Older Adults: A Randomized, Placebo-Controlled Crossover Study |
| Q96430976 | Brd4 inhibition ameliorates Pyocyanin-mediated macrophage dysfunction via transcriptional repression of reactive oxygen and nitrogen free radical pathways |
| Q96953131 | Determination of Endothelial Nitric Oxide Synthase Gene Polymorphism and Plasma Asymmetric Dimethyl Arginine Concentrations in Patients with Lung Cancer |
| Q57169789 | Glycocalyx Preservation and NO Production in Fatty Livers-The Protective Role of High Molecular Polyethylene Glycol in Cold Ischemia Injury |
| Q90108308 | Hormesis in Health and Chronic Diseases |
| Q93257464 | Hormonal control of the crustacean molting gland: Insights from transcriptomics and proteomics |
| Q52682702 | Identification of candidate genes associated with fibromyalgia susceptibility in southern Spanish women: the al-Ándalus project. |
| Q64942530 | Interplay between circulating nitric oxide and interleukin-17 in elderly outpatients with non-inflammatory conditions. |
| Q93122173 | Loss of smooth muscle CYB5R3 amplifies angiotensin II-induced hypertension by increasing sGC heme oxidation |
| Q38750287 | Metabolomics for clinical use and research in chronic kidney disease |
| Q33700821 | Moderate Treadmill Exercise Training Improves Cardiovascular and Nitrergic Response and Resistance to Trypanosoma cruzi Infection in Mice |
| Q38693904 | NO-Donor Iron Nitrosyl Complex with N-Ethylthiourea Ligand Exhibits Selective Toxicity to Glioma A172 Cells |
| Q48227721 | Nasal ventilation is an important factor in evaluating the diagnostic value of nasal nitric oxide in allergic rhinitis. |
| Q89567506 | Nitrosyl-hemoglobin formation in rodent and human venous erythrocytes reflects NO formation from the vasculature in vivo |
| Q64091441 | Role of Combined Lipoic Acid and Vitamin D3 on Astrocytes as a Way to Prevent Brain Ageing by Induced Oxidative Stress and Iron Accumulation |
| Q47664739 | Soluble guanylate cyclase stimulation reduces oxidative stress in experimental Chronic Obstructive Pulmonary Disease. |
| Q64276811 | The Selective Acetamidine-Based iNOS Inhibitor CM544 Reduces Glioma Cell Proliferation by Enhancing PARP-1 Cleavage In Vitro |
Search more.